Plasma cell depletion as an approach to reset autoimmunity in rheumatoid arthritis - Trial 2021-006669-40
Access comprehensive clinical trial information for 2021-006669-40 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitätsklinikum Erlangen and is currently Ongoing. The study focuses on Rheumatoid arthritis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2021-006669-40
Ongoing
Trial Details
EU Clinical Trials Register • 2021-006669-40
Plasma cell depletion as an approach to reset autoimmunity in rheumatoid arthritis
Study Focus
Sponsor & Location
Universitätsklinikum Erlangen
Janssen-Cilag GmbH
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
• Planned or ongoing pregnancy or breast-feeding
ICD-10 Classifications
Rheumatoid arthritis, unspecified
Other rheumatoid arthritis
Other specified rheumatoid arthritis
Rheumatoid arthritis with involvement of other organs and systems
Seronegative rheumatoid arthritis
Data Source
EU Clinical Trials Register
2021-006669-40
Non-Device Trial